Signet Financial Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $326K | Buy |
2,579
+83
| +3% | +$10.5K | 0.04% | 233 |
|
|
2025
Q1 | $319K | Sell |
2,496
-89
| -3% | -$11.4K | 0.04% | 232 |
|
|
2024
Q4 | $342K | Sell |
2,585
-26
| -1% | -$3.44K | 0.04% | 215 |
|
|
2024
Q3 | $380K | Sell |
2,611
-38
| -1% | -$5.53K | 0.05% | 208 |
|
|
2024
Q2 | $364K | Buy |
2,649
+78
| +3% | +$10.7K | 0.05% | 207 |
|
|
2024
Q1 | $353K | Buy |
2,571
+53
| +2% | +$7.27K | 0.05% | 214 |
|
|
2023
Q4 | $342K | Sell |
2,518
-60
| -2% | -$8.15K | 0.05% | 219 |
|
|
2023
Q3 | $315K | Sell |
2,578
-15
| -0.6% | -$1.84K | 0.05% | 216 |
|
|
2023
Q2 | $329K | Buy |
2,593
+17
| +0.7% | +$2.16K | 0.05% | 220 |
|
|
2023
Q1 | $333K | Sell |
2,576
-56
| -2% | -$7.23K | 0.06% | 221 |
|
|
2022
Q4 | $346K | Sell |
2,632
-171
| -6% | -$22.4K | 0.06% | 210 |
|
|
2022
Q3 | $328K | Buy |
2,803
+692
| +33% | +$81K | 0.06% | 199 |
|
|
2022
Q2 | $248K | Buy |
2,111
+301
| +17% | +$35.4K | 0.05% | 225 |
|
|
2022
Q1 | $236K | Sell |
1,810
-176
| -9% | -$22.9K | 0.04% | 229 |
|
|
2021
Q4 | $303K | Buy |
1,986
+357
| +22% | +$54.5K | 0.05% | 215 |
|
|
2021
Q3 | $263K | Buy |
+1,629
| New | +$263K | 0.05% | 223 |
|
|
2021
Q1 | – | Sell |
-1,368
| Closed | -$207K | – | 239 |
|
|
2020
Q4 | $207K | Buy |
+1,368
| New | +$207K | 0.04% | 218 |
|
|
2018
Q4 | – | Sell |
-525
| Closed | -$64K | – | 480 |
|
|
2018
Q3 | $64K | Buy |
525
+54
| +11% | +$6.58K | 0.01% | 365 |
|
|
2018
Q2 | $52K | Sell |
471
-43
| -8% | -$4.75K | 0.01% | 382 |
|
|
2018
Q1 | $55K | Buy |
+514
| New | +$55K | 0.01% | 351 |
|